Biosurgery Market

Biosurgery Market by Product (Fibrin & Collagen Sealant, Hemostats, Adhesion Barriers, Biological Meshs, Soft Tissue Attachments, Stapler, Bone Graft Substitutes) Application (Orthopedic, Gynecology, Cardiovascular, Reconstructive) - Forecast to 2023

Report Code: MD 3554 Nov, 2019, by marketsandmarkets.com
Updated date -

MarketsandMarkets forecasts the biosurgery market to grow from USD 11,365.0 million in 2018 to USD 15,581.7 million by 2023, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period. The major factors that are expected to be driving the biosurgery market are the rising geriatric population, increase in the volume of surgeries and sports-related and trauma injuries, increasing clearance of biosurgery products by regulatory authorities and growing need for effective blood loss management in patients. The objective of the report is to define, describe, and forecast the biosurgery market size based on product, application, and region.

Biosurgery Market

By products, the surgical sealants and adhesives segment is expected to grow at the highest growth rate during the forecast period

The biosurgery market, by product, is segmented into bone-graft substitutes, soft-tissue attachments, surgical sealants and adhesives, hemostatic agents, adhesion barriers, and staple-line reinforcement agents. Among the products segment, the surgical sealants and adhesives segment is expected to grow at the highest CAGR during the forecast period. The total number of surgeries being performed annually is increasing owing to the growing geriatric population, rising prevalence of lifestyle diseases (such as cardiovascular and orthopedic diseases), and growing number of people suffering from lower back pain and sports-related injuries, thereby attributing to high growth of this segment.

  • In 2017, the bone-graft substitutes market segment accounted for the largest share of the biosurgery market, owing to their popularity in fractures and spine and foot reconstruction surgeries, rising incidences of sports-related injuries and lower back disorders, and growing geriatric population.
  • The soft-tissue attachments segment is then further subsegmented into, synthetic meshes, and biological meshes. The growth in biological meshes market can majorly be attributed to the biocompatibility of biological meshes and their increasing application in soft-tissue repair for various indications.
  • The hemostatic agents market is characterized by the presence of several players. A majority of players in this segment are continuously focusing on improving their market share and presence through new product launches, acquisitions, and expansions.

By applications, the orthopedic surgery segment is expected to account for the largest share of the biosurgery market

On the basis of applications, the biosurgery market is segmented into neurological surgery, cardiovascular surgery, general surgery, orthopedic surgery, thoracic surgery, gynecological surgery, urological surgery, and reconstructive surgery. The orthopedic surgery segment is expected to account for the largest share of the biosurgery market during the forecast period. The large share of this segment can be attributed to the large number of orthopedic bone and soft tissue repair surgeries being performed globally, on an annual basis. The growing number of orthopedic surgeries is in turn expected to support the growth of dependent markets, such as the biosurgery market for orthopedic applications.

Biosurgery Market

North America to account for the largest market size during the forecast period.

North America is expected to hold the largest market size in the biosurgery market during the forecast period. The highest market share of North America is due to the presence of a well-developed healthcare system, increasing volume of surgical procedures performed, large number of hospitals, and presence of leading market players in the region. The Asia Pacific market is expected to witness the highest growth rate during the forecast period. The high growth in this market is attributed to the increasing prevalence of chronic diseases, increasing per capita income leading to improving standard of living, increasing healthcare spending, growing demand for better quality medical care, and rising awareness about biosurgery products in the region.

Market Dynamics

Driver: Increasing volume of surgeries and prevalence of severe trauma injuries

Changing lifestyles and eating habits have resulted in a significant increase in the prevalence of obesity and other lifestyle disorders. This is a major factor responsible for the growth in the number of surgeries performed every year across the globe. Biosurgery products play a critical role in controlling blood loss, healing wounds, and in closing the surgical sites during different types of surgeries. Owing to the proven benefits of biosurgery products and the growing awareness for the same, the overall uptake of different surgical sealants and hemostatic agents during surgical procedures is increasing. This is one of the key contributors to the growth of the biosurgery market. According to the National Center for Biotechnology Information (NCBI) (US), there has been a significant increase in the number of surgical procedures in the US over the last decade, and this trend is expected to continue in the coming years.

Restraint: High price of biosurgery products and rising cost of surgical procedures

Currently, the biosurgery products market is extremely competitive in terms of pricing owing to the high competitive intensity among existing players. Most of the biosurgery products are premium-priced products. This, coupled with the unfavorable reimbursement scenario for these products in several countries, makes them unaffordable for a large section of the target patient population. Also, the biosurgery products currently available in the market are made of complicated reconstitutes with a poor shelf life. Owing to these factors, there is a growing need for low-priced products that are easy to handle and have a better shelf life. The cost of surgical procedures has increased considerably over the years due to factors such as consolidation of healthcare providers, rising expenses owing to the use of complex medical procedures, changing government regulations, and constrained resources. Postoperative complications such as excessive bleeding, infections, and the recurrence of medical conditions such as hernia and respiratory problems further increase the cost of these surgeries. This is another major factor affecting the uptake of high-priced biosurgery products during surgical procedures. Thus, reducing the cost of surgical procedures as well as biosurgery products through R&D and innovations is a major challenge for players operating in this market.

Opportunity: Untapped emerging markets

The penetration of biosurgery products is very low in the Asia Pacific, Latin America, and the Middle East and Africa. In the coming years, countries such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the biosurgery market. This is because the markets in these countries are characterized by a large patient base for target indications (such as cardiovascular, orthopedic, general/abdominal, and gynecological disorders), rising health awareness, growing healthcare expenditure, rising medical tourism, and rapidly developing healthcare infrastructure. For instance, cardiovascular diseases are currently the leading cause of mortality in India. According to the Global Burden of Disease Study, 2016 (by the WHO), the estimated age-standardized CVD death rate is 272 per 100,000 population in India, which is higher than the global average of 235 per 100,000 population.

Challenge: Stringent regulatory framework

The development of new biosurgery products requires significant investments, and new products generally take more than 7–8 years for gaining marketing approval. For instance, in the US, the FDA has made it mandatory for biosurgery product manufacturers to obtain Premarket Approval (PMA) for their products before they are introduced in the market. For this, the product has to demonstrate proper clinical trials data, which has to be submitted along with the application for PMA. The cost and time required for a product to enter the clinical trial step and then clear the clinical trials are very high, with minimum chances of the product gaining approval. Also, the possibility of obtaining clinically significant data showing clinical trial clearance has been low for biosurgery products such as adhesion barriers, semi-synthetic sealants, and hemostatic agents. Hence, despite huge investments in R&D, the risk of failure is very high in the case of biosurgery products. This is a major factor limiting the development of novel biosurgery products in the market.

Biosurgery Market

Scope of the Report

Report Metric

Details

Market size available for years

2016–2023

Base year considered

2017

Forecast period

2018–2023

Forecast units

Million (USD)

Segments covered

Product, Application, and Region

Geographies covered

North America, Europe, APAC, MEA, and Latin America

Companies covered

Baxter International Inc. (US), C.R. Bard (US), Johnson & Johnson (US), and Medtronic plc. (Ireland), Sanofi Group (France), B. Braun Melsungen AG (Germany), MAQUET Holding B.V. & Co. KG. (Germany), Cryolife, Inc. (US), Stryker Corporation (US), and Hemostasis, LLC. (US), Integra Lifesciences Holdings Corporation (US), Cohera Medical Inc. (US), Pfizer Inc. (US), CSL Limited (Australia)

The research report categorizes the biosurgery market to forecast the revenues and analyze the trends in each of the following sub-segments:

Global Biosurgery Market, By Product

  • Surgical Sealants and adhesives
    • Natural/Biological Sealants, By Type
      • Fibrin Sealants
      • Collagen Based Sealants
      • Gelatin Based Sealants
      • Albumin Based Sealants
      • Others (Polysaccharide based sealants such as chitosan based sealants, dextran-based and chondroitin-based sealants)
    • Natural/Biological Sealants, By Origin
      • Human Blood Based
      • Animal Based Sealants
    • Synthetic/Semi-synthetic Sealants
      • Cyanoacrylates
      • Polymeric Hyrogels
      • Urethane-based Sealants
      • "Others (polyglycerol sebacate (PGS) and lactic acid (LA) based sealants)
  • Hemostatic Agents
    • Thrombin-Based
    • Oxidized Regenerated Cellulose Based Hemostats
    • Combination hemostats
    • Others (Gelatin, Collagen hemostat)
  • Adhesion Barriers
    • Synthetic Adhesion Barriers
      • Hyaluronic Acid
      • Regenarated Cellulose
      • Polyethylene Glycol (PEG)
      • Others
    • Natural Adhesion Barriers
      • Collagen & Protein
      • Fibrin Based
  • Soft Tissue Attachments (Soft Tissue Patch/Mesh)
    • Synthetic Mesh
    • Biological Mesh
      • Allograft
      • Xenograft
  • Bone Graft Substitutes
    • Demineralized Bone Matrix (DBM)
    • Bone Morphogenetic Proteins (BMP)Synthetic Bone Grafts
    • Synthetic Bone Grafts
    • Others (Ceramic, Composite, Polymer)
  • Staple Line Reinforcement Agents

Global Biosurgery Market, By Application

  • Gynecological Surgeries
  • General/Abdominal Surgeries
  • Orthopedic Surgeries
  • Cardiovascular Surgeries
  • Neurological Surgeries
  • Urological Surgeries
  • Reconstructive Surgeries
  • Thoracic Surgeries
  • Other Surgeries**
  • **Other surgeries include ear, nose, throat, and burn surgeries

Global Biosurgery Market, By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • Australia
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLATAM)
  • Middle East and Africa

Key Market Players

Baxter International (US), Johnson & Johnson (J&J) (US), Medtronic plc (Ireland), Sanofi (France), C.R. Bard (US), Integra LifeSciences (US), and Maquet holdings (Sweden), lead the global biosurgery market. Some of the other leading players in this market include Cohera Medical (US), Hemostasis LLC. (US), Stryker Corporation (US), B.Braun Melsungen AG (Germany), CSL Limited (Australia), Pfizer Inc. (US), and Cryolife Inc. (US).

Baxter International (US) dominates the global biosurgery market with the largest share in 2017. The company offers wide portfolio in biosurgery market, and further seeks to strengthen its product offerings through product enhancements and by expanding its advanced surgery product portfolio which includes FLOSEAL Hemostatic Matrix and TISSEEL through product acquisitions in April 2017. The company’s strong presence and its worldwide sales channel in approximately 100 countries will ensure its future growth in the biosurgery market. The high growth potential in developing regions offers significant growth opportunities for the company. It generates most of its revenue from developed regions such as North America and some of the European countries.

Recent Developments

  • In April 2018, Medtronic plc received FDA approval for its infuse bone graft to use with additional spine implants made of polyetheretherketone (PEEK). This is specifically approved for spine, oral-maxillofacial, and orthopedic trauma surgeries.
  • In November 2017, Johnson & Johnson collaborated with Houston’s Texas Medical Center (US) to develop a facility for device innovation and to broaden the medical device product portfolio.
  • In July 2017, Baxter partnered with Tel Aviv University and Tel Aviv Sourasky Medical Center to bring new surgical innovations to the global market.
  • In February 2017, Integra LifeSciences Holding Corporation acquired the Johnson and Johnson’s business segment named Codman Neurosurgery. This segment broadened the portfolio of Integra and enhanced its position in the neurosurgery market.
  • In April 2016, under the agreement with AlloSource (US), Integra gained access to soft tissue repair solutions.

Critical questions the report answers:

  • Where will all these developments take the industry in the long term?
  • What are the upcoming trends for the biosurgery market?
  • Which segment provides the most opportunity for growth?
  • Who are the leading vendors operating in this market?
  • What are the opportunities for new market entrants?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Biosurgery Market: Introduction (Page No. - 26)
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Markets Covered
           1.2.2 Years Considered for the Study
    1.3 Currency
    1.4 Limitations
    1.5 Stakeholders

2 Biosurgery Market: Research Methodology (Page No. - 30)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Assumptions for the Study

3 Biosurgery Market: Executive Summary (Page No. - 40)

4 Biosurgery Market: Premium Insights (Page No. - 47)
    4.1 Market: Overview
    4.2 APAC: Market, By Type & Country (2017)
    4.3 Geographic Snapshot of the Market (2017)
    4.4 Geographic Mix: Market, 2016 — 2023 (USD Million)
    4.5 Biosugery Market: Developing vs Developed Markets, 2018 vs 2023 (USD Million)

5 Biosurgery Market: Overview (Page No. - 51)
    5.1 Introduction
    5.2 Drivers
           5.2.1 Rising Geriatric Population
           5.2.2 Increasing Volume of Surgeries and Prevalence of Severe Trauma Injuries
           5.2.3 Strong Focus on R&D Leading to the Launch of New and Advanced Products
           5.2.4 Rising Need for Effective Blood Loss Management in Patients
    5.3 Market Restraints
           5.3.1 High Price of Biosurgery Products & Rising Cost of Surgical Procedures
    5.4 Biosurgery Market Opportunities
           5.4.1 Untapped Emerging Markets
    5.5 Market Challenges
           5.5.1 Stringent Regulatory Framework
           5.5.2 Requirement of Skilled Personnel for the Effective Use of Biosurgery Products

6 Industry Insights (Page No. - 57)
    6.1 Industry Trends
           6.1.1 Increasing Market Consolidation
           6.1.2 Rising Focus on Product Developments & Launches
           6.1.3 Growing Demand for Dental Bone-Graft Substitutes
           6.1.4 Growing Preference for Gelatin-Based Adhesives & Hydrogels in Surgical Procedures
    6.2 Regulatory Analysis
           6.2.1 North America
                    6.2.1.1 US
                    6.2.1.2 Canada
           6.2.2 Europe
           6.2.3 APAC
                    6.2.3.1 Japan
                    6.2.3.2 China
                    6.2.3.3 India
    6.3 Strategic Benchmarking
           6.3.1 Market: Product Portfolio Analysis
           6.3.2 Natural/Biological Sealants & Adhesives: Product Portfolio Analysis
           6.3.3 Synthetic & Semisynthetic Sealants & Adhesives: Product Portfolio Analysis
           6.3.4 Hemostatic Agents: Product Portfolio Analysis
           6.3.5 Adhesion Barriers: Product Portfolio Analysis
           6.3.6 Soft-Tissue Attachments: Product Portfolio Analysis
           6.3.7 Bone-Graft Substitutes : Product Portfolio Analysis

7 Biosurgery Market, By Product (Page No. - 74)
    7.1 Introduction
    7.2 Bone-Graft Substitutes
           7.2.1 Demineralized Bone Matrix
           7.2.2 Synthetic Bone Grafts
           7.2.3 Bone Morphogenetic Proteins
           7.2.4 Other Bone-Graft Substitutes
    7.3 Soft-Tissue Attachments
           7.3.1 Synthetic Meshes
           7.3.2 Biological Meshes
                    7.3.2.1 Allografts
                    7.3.2.2 Xenografts
    7.4 Hemostatic Agents
           7.4.1 Thrombin-Based Hemostatic Agents
           7.4.2 Oxidized Regenerated Cellulose-Based Hemostatic Agents
           7.4.3 Combination Hemostatic Agents
    7.5 Surgical Sealants and Adhesives
           7.5.1 Natural/Biological Sealants and Adhesives
                    7.5.1.1 Natural/Biological Sealants and Adhesives, By Type
                               7.5.1.1.1 Fibrin Sealants
                               7.5.1.1.2 Collagen-Based Sealants
                               7.5.1.1.3 Gelatin-Based Sealants
                               7.5.1.1.4 Albumin-Based Sealants
                               7.5.1.1.5 Other Natural/Biological Sealants
                    7.5.1.2 Natural/Biological Sealants and Adhesives, By Origin
                               7.5.1.2.1 Human Blood-Based Sealants and Adhesives
                               7.5.1.2.2 Animal-Based Sealants and Adhesives
           7.5.2 Synthetic and Semi-Synthetic Sealants and Adhesives
                    7.5.2.1 Peg Hydrogels
                    7.5.2.2 Cyanoacrylate-Based Sealants and Adhesives
                    7.5.2.3 Urethane-Based Sealants and Adhesives
                    7.5.2.4 Other Synthetic and Semi-Synthetic Sealants and Adhesives
    7.6 Adhesion Barriers
           7.6.1 Synthetic Adhesion Barriers
                    7.6.1.1 Hyaluronic Acid-Based Adhesion Barriers
                    7.6.1.2 Regenerated Cellulose-Based Adhesion Barriers
                    7.6.1.3 Peg-Based Adhesion Barriers
                    7.6.1.4 Ther Synthetic Adhesion Barriers
           7.6.2 Natural Adhesion Barriers
                    7.6.2.1 Collagen & Protein Adhesion Barriers
                    7.6.2.2 Fibrin-Based Adhesion Barriers
    7.7 Staple-Line Reinforcement Agents

8 Biosurgery Market, By Application (Page No. - 134)
    8.1 Introduction
    8.2 Orthopedic Surgery
    8.3 General Surgery
    8.4 Neurological Surgery
    8.5 Cardiovascular Surgery
    8.6 Reconstructive Surgery
    8.7 Gynecological Surgery
    8.8 Urological Surgery
    8.9 Thoracic Surgery

9 Biosurgery Market, By Region (Page No. - 147)
    9.1 Introduction
    9.2 North America
           9.2.1 US
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 UK
           9.3.3 France
           9.3.4 Italy
           9.3.5 Spain
           9.3.6 Rest of Europe (RoE)
    9.4 Asia Pacific
           9.4.1 Japan
           9.4.2 China
           9.4.3 India
           9.4.4 Rest of Asia Pacific
    9.5 Latin America
           9.5.1 Brazil
           9.5.2 Mexico
           9.5.3 Rest of Latin America
    9.6 Middle East and Africa

10 Biosurgery Market: Competitive Landscape (Page No. - 252)
     10.1 Overview
     10.2 Market Share Analysis
             10.2.1 Surgical Sealants and Adhesives
             10.2.2 Hemostatic Agents
             10.2.3 Bone-Graft Substitutes
             10.2.4 Adhesion Barriers
             10.2.5 Soft-Tissue Attachments
     10.3 Competitive Situations and Trends
             10.3.1 Product Launches and Approvals
             10.3.2 Agreements and Partnerships
             10.3.3 Acquisitions
             10.3.4 Expansions

11 Company Profiles (Page No. - 263)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
     11.1 Baxter International, Inc.
     11.2 B.Braun Melsungen AG
     11.3 C.R. Bard
     11.4 Johnson & Johnson
     11.5 Medtronic, PLC.
     11.6 MAQUET Holding B.V. & Co. Kg. (Getinge Group)
     11.7 Cohera Medical Inc.
     11.8 Integra Lifesciences Holdings Corporation
     11.9 Commonwealth Serum Laboratories (CSL)
     11.10 Hemostasis, LLC
     11.11 Sanofi
     11.12 Pfizer Inc.
     11.13 Stryker Corporation
     11.14 Cryolife, Inc.

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 303)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Introducing RT: Real-Time Market Intelligence
     12.5 Available Customizations
     12.6 Related Report
     12.7 Author Details


List of Tables (352 Tables)

Table 1 Standard Currency Conversion Rates
Table 2 Biosurgery Market Snapshot
Table 3 Market Dynamics: Impact Analysis
Table 4 Percentage Increase in the Number of Surgical Procedures Performed in the US
Table 5 Major Acquisitions in the Market (2015–2017)
Table 6 Number of Product Launches By Key Players (2015–2018)
Table 7 Indicative List of Regulatory Authorities Governing Medical Devices
Table 8 Stringency of Regulations for Biosurgery Products, By Country
Table 9 Market, By Product, 2016–2023 (USD Million)
Table 10 Market for Bone-Graft Substitutes, By Type, 2016–2023 (USD Million)
Table 11 Biosurgery Market for Bone-Graft Substitutes, By Country, 2016–2023 (USD Million)
Table 12 Major Products in the DBM Market
Table 13 Demineralized Bone Matrix Market, By Country, 2016–2023 (USD Million)
Table 14 Major Products in the Synthetic Bone Grafts Market
Table 15 Synthetic Bone Grafts Market, By Country, 2016–2023 (USD Million)
Table 16 Major Products in the Bone Morphogenetic Proteins Market
Table 17 Bone Morphogenetic Proteins Market, By Country, 2016–2023 (USD Million)
Table 18 Major Products in the Other Bone-Graft Substitutes Market
Table 19 Other Bone-Graft Substitutes Market, By Country, 2016–2023 (USD Million)
Table 20 Biosurgery Market for Soft-Tissue Attachments, By Type, 2016-2023 (USD Million)
Table 21 Market for Soft-Tissue Attachments, By Country, 2016-2023 (USD Million)
Table 22 Major Products in the Synthetic Meshes Market
Table 23 Synthetic Meshes Market, By Country, 2016–2023 (USD Million)
Table 24 Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 25 Biological Meshes Market, By Country, 2016–2023 (USD Million)
Table 26 Allografts Market, By Country, 2016–2023 (USD Million)
Table 27 Xenografts Market, By Country, 2016–2023 (USD Million)
Table 28 Market for Hemostatic Agents, By Type, 2016-2023 (USD Million)
Table 29 Biosurgery Market for Hemostatic Agents, By Country, 2016-2023 (USD Million)
Table 30 Major Products in the Thrombin-Based Hemostatic Agents Market
Table 31 Thrombin-Based Hemostatic Agents Market, By Country, 2016-2023 (USD Million)
Table 32 Major Products in the Oxidized Regenerated Cellulose-Based Hemostatic Agents Market
Table 33 Oxidized Regenerated Cellulose-Based Hemostatic Agents Market, By Country, 2016-2023 (USD Million)
Table 34 Major Products in the Combination Hemostatic Agents
Table 35 Combination Hemostats Market, By Country, 2016-2023 (USD Million)
Table 36 Biosurgery Market for Surgical Sealants and Adhesives, By Type, 2016-2023 (USD Million)
Table 37 Market for Surgical Sealants and Adhesives Market, By Country, 2016–2023 (USD Million)
Table 38 Market for Natural/Biological Sealants and Adhesives, By Type, 2016–2023 (USD Million)
Table 39 Biosurgery Market for Natural/Biological Sealants and Adhesives, By Country, 2016–2023 (USD Million)
Table 40 Major Products in the Fibrin Sealants Market
Table 41 Fibrin Sealants Market, By Country, 2016–2023 (USD Million)
Table 42 Major Products in the Collagen Based-Sealants Market
Table 43 Collagen-Based Sealants Market, By Country, 2016–2023 (USD Million)
Table 44 Major Products in the Gelatin Based-Sealants Market
Table 45 Gelatin-Based Sealants Market , By Country, 2016–2023 (USD Million)
Table 46 Major Products in the Albumin Based-Sealants Market
Table 47 Albumin-Based Sealants Market, By Country, 2016–2023 (USD Million)
Table 48 Other Natural/Biological Sealants Market, By Country, 2016–2023 (USD Million)
Table 49 Natural/Biological Sealants and Adhesives Market, By Origin, 2016-2023 (USD Million)
Table 50 Human Blood-Based Sealants and Adhesives Market, By Country, 2016-2023 (USD Million)
Table 51 Animal-Based Sealants and Adhesives Market, By Country, 2016-2023 (USD Million)
Table 52 Synthetic and Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 53 Synthetic and Semi-Synthetic Sealants and Adhesives Market, By Country, 2016-2023 (USD Million)
Table 54 Major Products in the Peg Hydrogel-Based Sealants and Adhesives Market
Table 55 Peg Hydrogel-Based Sealants and Adhesives Market, By Country, 2016-2023 (USD Million)
Table 56 Major Products in the Cyanoacrylate-Based Sealants and Adhesives Market
Table 57 Cyanoacrylate-Based Sealants and Adhesives Market, By Country, 2016-2023 (USD Million)
Table 58 Major Urethane-Based Sealants and Adhesives in the Market
Table 59 Urethane-Based Sealants and Adhesives Market, By Country, 2016-2023 (USD Million)
Table 60 Other Synthetic and Semi-Synthetic Sealants and Adhesives Market, By Country, 2016-2023 (USD Million)
Table 61 Market for Adhesion Barriers, By Type, 2016-2023 (USD Million)
Table 62 Biosurgery Market for Adhesion Barriers, By Country, 2016-2023 (USD Million)
Table 63 Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 64 Synthetic Adhesion Barriers Market, By Country, 2016–2023 (USD Million)
Table 65 Major Products in the Hyaluronic Acid-Based Adhesion Barriers Market
Table 66 Hyaluronic Acid-Based Adhesion Barriers Market, By Country, 2016–2023 (USD Million)
Table 67 Major Products in the Regenerated Cellulose-Based Adhesion Barriers Market
Table 68 Regenerated Cellulose-Based Adhesion Barriers Market, By Country, 2016–2023 (USD Million)
Table 69 Major Products in the Peg-Based Adhesion Barriers Market
Table 70 Peg-Based Adhesion Barriers Market, By Country, 2016–2023 (USD Million)
Table 71 Major Products in the Other Synthetic Adhesion Barriers Market
Table 72 Other Synthetic Adhesion Barriers Market, By Country, 2016–2023 (USD Million)
Table 73 Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 74 Natural Adhesion Barriers Market, By Country, 2016–2023 (USD Million)
Table 75 Major Products in the Collagen and Protein Adhesion Barriers Market
Table 76 Collagen and Protein Adhesion Barriers Market, By Country, 2016–2023 (USD Million)
Table 77 Major Products in the Fibrin-Based Adhesion Barriers Market
Table 78 Fibrin-Based Adhesion Barriers Market, By Country, 2016–2023 (USD Million)
Table 79 Major Products in the Staple-Line Reinforcement Agents Market
Table 80 Biosurgery Market for Staple-Line Reinforcement Agents, By Country, 2016–2023 (USD Million)
Table 81 Market, By Application, 2016–2023 (USD Million)
Table 82 Orthopedic Surgery Market, By Country, 2016–2023 (USD Million)
Table 83 General Surgery Market, By Country, 2016–2023 (USD Million)
Table 84 Neurological Surgery Market, By Country, 2016–2023 (USD Million)
Table 85 Cardiovascular Surgery Market, By Country, 2016–2023 (USD Million)
Table 86 Reconstructive Surgery Market, By Country, 2016–2023 (USD Million)
Table 87 Countries With the Highest C-Section Rate (2015)
Table 88 Gynecological Surgery Market, By Country, 2016–2023 (USD Million)
Table 89 Urological Surgery Market, By Country, 2016–2023 (USD Million)
Table 90 Thoracic Surgery Market, By Country, 2016–2023 (USD Million)
Table 91 Biosurgery Market, By Region, 2016–2023 (USD Million)
Table 92 North America: Market, By Country, 2016–2023 (USD Million)
Table 93 North America: Market, By Product, 2016–2023 (USD Million)
Table 94 North America: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 95 North America: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 96 North America: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 97 North America: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 98 North America: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 99 North America: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 100 North America: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 101 North America: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 102 North America: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 103 North America: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 104 North America: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 105 US: Key Macroindicators for the Market
Table 106 US: Market, By Product, 2016–2023 (USD Million)
Table 107 US: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 108 US: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 109 US: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 110 US: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 111 US: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 112 US: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 113 US: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 114 US: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 115 US: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 116 US: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 117 US: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 118 Canada: Key Macroindicators for the Biosurgery Market
Table 119 Canada: Market, By Product, 2016–2023 (USD Million)
Table 120 Canada: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 121 Canada: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 122 Canada: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 123 Canada: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 124 Canada: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 125 Canada: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 126 Canada: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 127 Canada: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 128 Canada: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 129 Canada: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 130 Canada: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 131 Europe: Market, By Country, 2016–2023 (USD Million)
Table 132 Europe: Market, By Product, 2016–2023 (USD Million)
Table 133 Europe: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 134 Europe: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 135 Europe: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 136 Europe: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 137 Europe: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 138 Europe: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 139 Europe: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 140 Europe: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 141 Europe: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 142 Europe: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 143 Europe: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 144 Germany: Key Macroindicators for the Biosurgery Market
Table 145 Germany: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 146 Germany: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 147 Germany: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 148 Germany: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 149 Germany: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 150 Germany: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 151 Germany: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 152 Germany: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 153 Germany: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 154 Germany: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 155 Germany: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 156 Germany: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 157 UK: Key Macroindicators for the Biosurgery Market
Table 158 UK: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 159 UK: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 160 UK: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 161 UK: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 162 UK: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 163 UK: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 164 UK: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 165 UK: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 166 UK: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 167 UK: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 168 UK: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 169 UK: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 170 France: Key Macroindicators for the Bosurgery Market
Table 171 France: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 172 France: Surgical Sealants and Adhesives Market, By Type, 2016–2023 (USD Million)
Table 173 France: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 174 France: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 175 France: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 176 France: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 177 France: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 178 France: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 179 France: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 180 France: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 181 France: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 182 France: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 183 Italy: Key Macroindicators for the Biosurgery Market
Table 184 Italy: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 185 Italy: Surgical Sealants and Adhesives Market, By Type, 2016–2023 (USD Million)
Table 186 Italy: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 187 Italy: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 188 Italy: Synthetic and Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 189 Italy: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 190 Italy: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 191 Italy: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 192 Italy: Soft-Tissue Attachment Market, By Type, 2016–2023 (USD Million)
Table 193 Italy: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 194 Italy: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 195 Italy: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 196 Spain: Key Macroindicators for the Biosurgery Market
Table 197 Spain: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 198 Spain: Surgical Sealants and Adhesives Market, By Type, 2016–2023 (USD Million)
Table 199 Spain: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 200 Spain: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 201 Spain: Synthetic and Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 202 Spain: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 203 Spain: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 204 Spain: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 205 Spain: Soft-Tissue Attachment Market, By Type, 2016–2023 (USD Million)
Table 206 Spain: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 207 Spain: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 208 Spain: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 209 RoE: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 210 RoE: Surgical Sealants and Adhesives Market, By Type, 2016–2023 (USD Million)
Table 211 RoE: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 212 RoE: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 213 RoE: Synthetic and Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 214 RoE: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 215 RoE: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 216 RoE: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 217 RoE: Soft-Tissue Attachment Market, By Type, 2016–2023 (USD Million)
Table 218 RoE: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 219 RoE: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 220 RoE: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 221 APAC: Biosurgery Market, By Country, 2016–2023 (USD Million)
Table 222 APAC: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 223 APAC: Surgical Sealants and Adhesives Market, By Type, 2016–2023 (USD Million)
Table 224 APAC: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 225 APAC: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 226 APAC: Synthetic and Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 227 APAC: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 228 APAC: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 229 APAC: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 230 APAC: Soft-Tissue Attachment Market, By Type, 2016–2023 (USD Million)
Table 231 APAC: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 232 APAC: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 233 APAC: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 234 Japan: Key Macroindicators for the Biosurgery Market
Table 235 Japan: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 236 Japan: Surgical Sealants and Adhesives Market, By Type, 2016–2023 (USD Million)
Table 237 Japan: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 238 Japan: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 239 Japan: Synthetic and Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 240 Japan: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 241 Japan: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 242 Japan: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 243 Japan: Soft-Tissue Attachment Market, By Type, 2016–2023 (USD Million)
Table 244 Japan: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 245 Japan: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 246 Japan: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 247 China: Key Macroindicators for the Biosurgery Market
Table 248 China: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 249 China: Surgical Sealants and Adhesives Market, By Type, 2016–2023 (USD Million)
Table 250 China: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 251 China: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 252 China: Synthetic and Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 253 China: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 254 China: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 255 China: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 256 China: Soft-Tissue Attachment Market, By Type, 2016–2023 (USD Million)
Table 257 China: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 258 China: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 259 China: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 260 India: Key Macroindicators for the Biosurgery Market
Table 261 India: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 262 India: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 263 India: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 264 India: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 265 India: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 266 India: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 267 India: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 268 India: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 269 India: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 270 India: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 271 India: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 272 India: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 273 RoAPAC: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 274 RoAPAC: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 275 RoAPAC: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 276 RoAPAC: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 277 RoAPAC: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 278 RoAPAC: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 279 RoAPAC: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 280 RoAPAC: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 281 RoAPAC: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 282 RoAPAC: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 283 RoAPAC: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 284 RoAPAC: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 285 Latin America: Biosurgery Market, By Country, 2016–2023 (USD Million)
Table 286 Latin America: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 287 Latin America: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 288 Latin America: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 289 Latin America: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 290 Latin America: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 291 Latin America: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 292 Latin America: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 293 Latin America: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 294 Latin America: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 295 Latin America: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 296 Latin America: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 297 Latin America: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 298 Brazil: Key Macroindicators for the Biosurgery Market
Table 299 Brazil: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 300 Brazil: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 301 Brazil: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 302 Brazil: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 303 Brazil: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 304 Brazil: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 305 Brazil: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 306 Brazil: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 307 Brazil: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 308 Brazil: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 309 Brazil: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 310 Brazil: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 311 Mexico: Key Macroindicators for the Biosurgery Market
Table 312 Mexico: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 313 Mexico: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 314 Mexico: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 315 Mexico: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 316 Mexico: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 317 Mexico: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 318 Mexico: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 319 Mexico: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 320 Mexico: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 321 Mexico: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 322 Mexico: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 323 Mexico: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 324 RoLA: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 325 RoLA: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 326 RoLA: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 327 RoLA: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 328 RoLA: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 329 RoLA: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 330 RoLA: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 331 RoLA: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 332 RoLA: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 333 RoLA: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 334 RoLA: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 335 Rest of Latin America: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 336 Middle East and Africa: Biosurgery Market, By Product, 2016–2023 (USD Million)
Table 337 Middle East and Africa: Surgical Sealants & Adhesives Market, By Type, 2016–2023 (USD Million)
Table 338 Middle East and Africa: Natural/Biological Sealants Market, By Type, 2016–2023 (USD Million)
Table 339 Middle East and Africa: Natural/Biological Sealants Market, By Origin, 2016–2023 (USD Million)
Table 340 Middle East and Africa: Synthetic & Semi-Synthetic Sealants Market, By Type, 2016–2023 (USD Million)
Table 341 Middle East and Africa: Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 342 Middle East and Africa: Natural Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 343 Middle East and Africa: Synthetic Adhesion Barriers Market, By Type, 2016–2023 (USD Million)
Table 344 Middle East and Africa: Soft-Tissue Attachments Market, By Type, 2016–2023 (USD Million)
Table 345 Middle East and Africa: Biological Meshes Market, By Type, 2016–2023 (USD Million)
Table 346 Middle East and Africa: Bone-Graft Substitutes Market, By Type, 2016–2023 (USD Million)
Table 347 Middle East and Africa: Biosurgery Market, By Application, 2016–2023 (USD Million)
Table 348 Growth Strategy Matrix (2015–2018)
Table 349 Product Launches, 2015–2018
Table 350 Agreements and Partnerships, 2015-2018
Table 351 Acquisitions, 2015-2018
Table 352 Expansions, 2015-2018
 
 
List of Figures (56 Figures)
 
Figure 1 Biosurgery Market
Figure 2 Biosurgery Market: Research Design
Figure 3 Primary Sources
Figure 4 Breakdown of Primary Interviews (Supply Side): By Company Type, Designation, and Region
Figure 5 Breakdown of Primary Interviews (Demand Side): By End User and Region
Figure 6 Data Triangulation Methodology
Figure 7 Biosurgery Market, By Type, 2018 vs 2023 (USD Million)
Figure 8 Natural/Biological Sealants Market, By Type, 2018 vs 2023 (USD Million)
Figure 9 Synthetic and Semi-Synthetic Sealants Market, By Type, 2018 vs 2023 (USD Million)
Figure 10 Hemostats Market, By Type, 2018 vs 2023 (USD Million)
Figure 11 Soft-Tissue Attachments Market, By Type, 2018 vs 2023 (USD Million)
Figure 12 Adhesion Barrier Market, By Type, 2018 vs 2023 (USD Million)
Figure 13 Synthetic Adhesion Barrier Market, By Type, 2018 vs 2023 (USD Million)
Figure 14 Bone-Graft Substitute Market, By Type, 2018 vs 2023 (USD Million)
Figure 15 Biosurgery Market, By Application, 2018 vs 2023 (USD Million)
Figure 16 Biosurgery Market Share, By Region
Figure 17 Increase in the Volume of Surgeries to Drive Market Growth
Figure 18 Bone-Graft Substitutes Held the Largest Share of the APAC Market in 2017
Figure 19 The US Accounted for the Largest Share of the Biosurgery Market in 2017
Figure 20 APAC to Grow at the Highest CAGR During the Forecast Period
Figure 21 Developing Markets to Register A Higher Growth During the Forecast Period
Figure 22 Growth in Geriatric Population, By Region, 2015–2050
Figure 23 Increasing Market Consolidation & Rising Focus on Product Developments are the Major Trends in the Biosurgery Market
Figure 24 Product Launches and Approvals - Key Growth Strategy Adopted By Major Players in the Biosurgery Market (2015–2018)
Figure 25 Premarket Notification: 510(K) Approval for Medical Devices
Figure 26 Biosurgery Market: Vendor Benchmarking
Figure 27 Bone-Graft Substitutes Segment to Dominate the Biosurgery Market in 2018
Figure 28 Demineralized Bone Matrix Segment to Grow at the Highest CAGR During the Forecast Period
Figure 29 Synthetic Meshes Segment to Grow at the Highest CAGR
Figure 30 Combination Hemostats Segment to Grow at the Highest CAGR During the Forecast Period
Figure 31 Synthetic and Semi-Synthetic Sealants Segment to Grow at the Highest CAGR During the Forecast Period
Figure 32 Human Blood-Based Sealants and Adhesives to Dominate the Natural/Biological Sealants & Adhesives Market
Figure 33 Synthetic Adhesion Barriers to Grow at the Highest CAGR During the Forecast Period
Figure 34 Orthopedic Surgery to Dominate the Biosurgery Applications Market During the Forecast Period
Figure 35 Geographic Snapshot: Markets in Asia Pacific are Emerging Hotspots
Figure 36 North America: Biosurgery Market Snapshot
Figure 37 Europe: Biosurgery Market Snapshot
Figure 38 APAC: Biosurgery Market Snapshot
Figure 39 Key Developments of Major Players Between January 2015 and March 2018
Figure 40 Surgical Sealants and Adhesives Market Share Analysis, By Key Player, 2017
Figure 41 Hemostatic Agents Market Share Analysis, By Key Player, 2017
Figure 42 Bone-Graft Substitutes Market Share Analysis, By Key Player, 2017
Figure 43 Adhesion Barriers Market Share Analysis, By Key Player, 2017
Figure 44 Soft-Tissue Attachments Market Share Analysis, By Key Player, 2017
Figure 45 Baxter International, Inc.: Company Snapshot (2017)
Figure 46 B.Braun Melsungen AG : Company Snapshot (2017)
Figure 47 C.R. Bard: Company Snapshot (2016)
Figure 48 Johnson & Johnson: Company Snapshot (2017)
Figure 49 Medtronic: Company Snapshot (2017)
Figure 50 Getinge Group: Company Snapshot (2017)
Figure 51 Integra Lifesciences Holdings Corporation: Company Snapshot (2017)
Figure 52 Commonwealth Serum Laboratories: Company Snapshot (2017)
Figure 53 Sanofi: Company Snapshot (2017)
Figure 54 Pfizer Inc.: Company Snapshot (2017)
Figure 55 Stryker Corporation: Company Snapshot (2017)
Figure 56 Cryolife: Company Snapshot (2017)


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 3554
Published ON
Nov, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Biosurgery Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home